Radius Residential CareNZSE:RAD -1.32%40 EBITDA Margin % is 10.41% as of Mar. 2026, which is 32% below its 10-year median of 15.27. GuruFocus rates NZSE:RAD with a GF Score™ of 40/100 and a GF Value™ of NZ$0.29 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Radius Residential Care ranks better than 62.01% on this metric.
Radius Residential Care (NZSE:RAD) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Radius Residential Care EBITDA Margin % Related Terms
Radius Residential Care EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:RAD vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Radius Residential Care's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Radius Residential Care EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Radius Residential Care's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Radius Residential Care's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Radius Residential Care (NZSE:RAD) has a EBITDA Margin % of 10.41% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Radius Residential Care and its competitors. This is 32% below median its historical median of 15.27. Over the past decade, Radius Residential Care's EBITDA Margin % has ranged from 11.83 to 20.16. According to the industry distribution chart, Radius Residential Care ranks #253 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 38%.
Is Radius Residential Care's EBITDA Margin % too high?
Radius Residential Care's current EBITDA Margin % of 10.41% is 32% below median its 10-year median of 15.27. Over the past 10 years, this metric has ranged from a low of 11.83 to a high of 20.16. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Radius Residential Care's value of 10.41% is 2% above this industry median. Based on the distribution chart, Radius Residential Care ranks #253 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Radius Residential Care has a GF Score™ of 40/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Radius Residential Care's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Radius Residential Care ranks #253 out of 666 companies for EBITDA Margin %. This puts Radius Residential Care in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Radius Residential Care's value of 10.41% is 2% above this benchmark. Historically, Radius Residential Care's own EBITDA Margin % has ranged from 11.83 to 20.16 over the past decade. While the company's 10-year median is 15.27 vs. the industry median of 10.21, Radius Residential Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Radius Residential Care's current EBITDA Margin % of 10.41% is 2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Radius Residential Care and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Radius Residential Care's current EBITDA Margin % is 10.41%, which is 32% below median its own 10-year median of 15.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Radius Residential Care stock overvalued right now?
Based on GuruFocus' analysis, Radius Residential Care (NZSE:RAD) is currently considered Modestly Overvalued. The stock's GF Value™ is NZ$0.29, compared to a current price of NZ$0.38 — trading 29.3% above its estimated fair value. The current EBITDA Margin % is 10.41%, which is 32% below median its 10-year median of 15.27 and 2% above the Healthcare Providers & Services industry median of 10.21. Radius Residential Care's overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Radius Residential Care (NZSE:RAD), the current EBITDA Margin % is 10.41% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Radius Residential Care (NZSE:RAD) Overvalued in 2026?
Based on GuruFocus' analysis, Radius Residential Care stock appears to be overvalued.
The current stock price of NZ$0.38 is trading 29.3% above its estimated GF Value™ of NZ$0.29.
GuruFocus considers Radius Residential Care to be Modestly Overvalued.
Key valuation signals for NZSE:RAD:
EBITDA Margin %: 10.41% (32% below median its 10-year median of 15.27)
GF Value™: NZ$0.29 vs. price of NZ$0.38 (29.3% above fair value)
Industry Position: 2% above the Healthcare Providers & Services median (#253 of 666)
No single metric tells the full story. See the NZSE:RAD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Radius Residential Care Ltd is a health and aged care provider for elderly and disabled people. The company provides residential care, hospital care, dementia care, respite care, and palliative care. Additionally, the company offers Young Disabled Care services for those under 65 who require assistance with self-care, mobility, and/or communication. It has one operating segment, being the provision of aged care in New Zealand.
40GF Score
Get the complete analysis for NZSE:RAD
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:RAD has been successfully added to your 
